Paul Yoo

AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA.

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.

CardioFocus, Inc. engages in the development and market of catheter-based approach to treating atrial fibrillation. The company was founded by Edward Sinofsky in 1990 and is headquartered in Marlborough, MA.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Matregen Corp. engaged in the development and commercialization of novel Drug Delivery Systems. Its SpinFX technology is a technique used to produce novel structures such as porous tubes, composites, and coatings. The company was founded by Dr. Molly S. Shoichet and Dr. Paul D. Dalton in 2002 and is headquartered in Toronto, Canada.

Cirtec Medical Systems LLC provides outsourced design and manufacturing services for neuro-stimulation and cardiovascular devices. Its services include products management, design and development, device assemble and product transfers. The company was founded by Laurence S. Derose, Merwin Jerry Hansen and Michael Forman in 2009 and is headquartered in Los Gatos, CA.

Ximedica LLC provides medical technology services. It develops endoscopic devices, laparoscopic tools, emergency care systems, infusion systems, urologic ablation and blood management devices. The company was founded by Stephen Lane and Aidan Petrie in 1985 and is headquartered in Providence, RI.

Therapeutic Monitoring Systems, Inc. develops clinical decision support software for use in critical care medicine. Its CIMVA software platform will be used by physicians and nurses in the hospital ICU and emergency department to improve how care is delivered, benefiting both patients and hospitals. The firm’s software is architected to facilitate point-of-care use by caregivers on browser-enabled central viewing stations or mobile devices. The company was founded by Andrew J. E. Seely in 2007 and is headquartered in Ottawa, Canada.

Guide Medical Ventures LLC develops medical devices. The firm focuses on technology improvements for existing medical procedures and applications. The company was founded by Scott Kokones and Vincent P. Owens in 2011 and is headquartered in Boston, MA.

CarePredict, Inc. offers wearable tech for seniors. It provides Tempo, a wrist-worn sensor that identifies and monitors a senior?s activities of daily living, as well as helps senior living staff and home care providers to identify the changes in daily activities that are precursors to serious health concerns. The company was founded by Satish Movva and Krishna Vedala in 2013 and is headquartered in Plantation, FL.

HUINNO Co., Ltd. develops software application that will help monitor how the body is doing while working, playing and sleeping. The company was founded by Steven Baek in 2014 and is headquartered in Seoul, South Korea.

Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada.

Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD.

Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021.